These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

499 related items for PubMed ID: 23612316

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ, Billingsley CC, Lankes HA, Ali S, Cohn DE, Broaddus RJ, Ramirez N, Pritchard CC, Hampel H, Chassen AS, Simmons LV, Schmidt AP, Gao F, Brinton LA, Backes F, Landrum LM, Geller MA, DiSilvestro PA, Pearl ML, Lele SB, Powell MA, Zaino RJ, Mutch D.
    J Clin Oncol; 2015 Dec 20; 33(36):4301-8. PubMed ID: 26552419
    [Abstract] [Full Text] [Related]

  • 3. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
    Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM.
    Am J Surg Pathol; 2014 Jun 20; 38(6):793-800. PubMed ID: 24503759
    [Abstract] [Full Text] [Related]

  • 4. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
    Hampel H, Frankel W, Panescu J, Lockman J, Sotamaa K, Fix D, Comeras I, La Jeunesse J, Nakagawa H, Westman JA, Prior TW, Clendenning M, Penzone P, Lombardi J, Dunn P, Cohn DE, Copeland L, Eaton L, Fowler J, Lewandowski G, Vaccarello L, Bell J, Reid G, de la Chapelle A.
    Cancer Res; 2006 Aug 01; 66(15):7810-7. PubMed ID: 16885385
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Feasibility of screening for Lynch syndrome among patients with colorectal cancer.
    Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Clendenning M, Sotamaa K, Prior T, Westman JA, Panescu J, Fix D, Lockman J, LaJeunesse J, Comeras I, de la Chapelle A.
    J Clin Oncol; 2008 Dec 10; 26(35):5783-8. PubMed ID: 18809606
    [Abstract] [Full Text] [Related]

  • 7. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
    Dillon JL, Gonzalez JL, DeMars L, Bloch KJ, Tafe LJ.
    Hum Pathol; 2017 Dec 10; 70():121-128. PubMed ID: 29107668
    [Abstract] [Full Text] [Related]

  • 8. Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center.
    Heald B, Plesec T, Liu X, Pai R, Patil D, Moline J, Sharp RR, Burke CA, Kalady MF, Church J, Eng C.
    J Clin Oncol; 2013 Apr 01; 31(10):1336-40. PubMed ID: 23401454
    [Abstract] [Full Text] [Related]

  • 9. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.
    Long Q, Peng Y, Tang Z, Wu C.
    Int J Clin Exp Pathol; 2014 Apr 01; 7(10):7297-303. PubMed ID: 25400828
    [Abstract] [Full Text] [Related]

  • 10. Comparison of screening strategies for Lynch syndrome in patients with newly diagnosed endometrial cancer: a prospective cohort study in China.
    Chao X, Li L, Wu M, Ma S, Tan X, Zhong S, Bi Y, Lang J.
    Cancer Commun (Lond); 2019 Jul 15; 39(1):42. PubMed ID: 31307542
    [Abstract] [Full Text] [Related]

  • 11. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
    Ryan P, Mulligan AM, Aronson M, Ferguson SE, Bapat B, Semotiuk K, Holter S, Kwon J, Kalloger SE, Gilks CB, Gallinger S, Pollett A, Clarke BA.
    Cancer; 2012 Feb 01; 118(3):681-8. PubMed ID: 21721000
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
    Adar T, Rodgers LH, Shannon KM, Yoshida M, Ma T, Mattia A, Lauwers GY, Iafrate AJ, Hartford NM, Oliva E, Chung DC.
    Cancer; 2018 Aug 01; 124(15):3145-3153. PubMed ID: 29750335
    [Abstract] [Full Text] [Related]

  • 17. Clustering of Lynch syndrome malignancies with no evidence for a role of DNA mismatch repair.
    Case AS, Zighelboim I, Mutch DG, Babb SA, Schmidt AP, Whelan AJ, Thibodeau SN, Goodfellow PJ.
    Gynecol Oncol; 2008 Feb 01; 108(2):438-44. PubMed ID: 18022218
    [Abstract] [Full Text] [Related]

  • 18. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
    McConechy MK, Talhouk A, Li-Chang HH, Leung S, Huntsman DG, Gilks CB, McAlpine JN.
    Gynecol Oncol; 2015 May 01; 137(2):306-10. PubMed ID: 25636458
    [Abstract] [Full Text] [Related]

  • 19. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
    Malander S, Rambech E, Kristoffersson U, Halvarsson B, Ridderheim M, Borg A, Nilbert M.
    Gynecol Oncol; 2006 May 01; 101(2):238-43. PubMed ID: 16360201
    [Abstract] [Full Text] [Related]

  • 20. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.
    Usha L, Dewdney SB, Buckingham LE.
    JAMA; 2016 Jul 05; 316(1):93-4. PubMed ID: 27380347
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.